News

Filter

Current filters:

Vertexboceprevir

Merck & Co’s hep C drug candidate boceprevir gets expedited review in USA and EU

07-01-2011

US drug giant Merck & Co (NYSE: MRK) says that regulatory applications for its investigational oral hepatitis…

Anti-viralsboceprevirMerck & CoPharmaceuticalRegulationtelaprevirVertex

COMPANY SPOTLIGHT

Menarini

Back to top